Caris Life Sciences, Inc.
- Last sale
- Nov 12, 2026 · -2.16%
- Market cap
- $6.87B
- 286.78M shares
- Filings
- 134
Q3 2026+97.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q1 2026+1,145.2% FY25 yoy
- $6.87B
- 71.5×
- 6.6×
- 10.7×
- 0.42%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $812,033,000 | reported | |
| FY 2024 | 2024-12-31 | $412,260,000 | reported | |
| FY 2023 | 2023-12-31 | $306,128,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $113.00K | $113.00K | — | 282.58M sh | +674.1% | 0.2% |
| FY2024 | — | $0.00 | $0.00 | — | 36.50M sh | — | — |
| FY2023 | — | $0.00 | $0.00 | — | — | — | — |
Segments
LineFY2025ShareChange
United States$801.39M99%+99.4%
International$10.64M1.3%+2.1%
Total$812.03M
Medical laboratories
Caris Life Sciences, Inc. is the 7th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
NTRANatera, Inc.$2.3B35.9%9.0%$46.8BRDNTRadNet, Inc.$2.0B11.5%0.9%$6.0BGHGuardant Health, Inc.$982.0M32.9%42.4%$20.9B
CAICaris Life Sciences, Inc. (this company)$812.0M97.0%8.4%$6.9B
VCYTVeracyte, Inc.$517.1M16.0%12.8%$2.0BCDNACareDx, Inc.$379.8M13.8%5.6%$4.4BCSTLCastle Biosciences Inc$344.2M3.7%7.0%$1.1BFLGTFulgent Genetics, Inc.$322.7M13.8%18.8%$693.9MBLLNBillionToOne, Inc.$305.1M100.0%2.4%$5.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Caris Life Sciences, Inc. · CIK 2019410 · Engraved from SEC EDGAR